Xellia signs distribution agreement on five generic drugs

Danish pharmaceutical company Xellia Pharmaceuticals has signed a distribution agreement with Indian Caplin Point Laboratories that allows Xellia to commercialize five generic drugs in the US.

Photo: Xellia Pharmaceuticals / PR

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try MedWatch for 14 days.

Get a trial subscription here.

Do you want a trial subscription with multiple users for yourself and your colleagues?

Read more about your options and find the contact information to our sales team here.

Related articles